Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,634,617
+$27,943,003 QoQ
Shares Held
4,783,989
+186.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#21
of 639 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $223,181,502 across 5 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (20.0% of the industry book) .
All Filings in HLN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,634,617 | 4,783,989 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,691,614 | 1,667,494 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,436,651 | 3,505,109 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,819,647 | 5,888,478 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $73,282,902 | 7,066,818 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $55,921,056 | 5,434,505 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,498,560 | 576,369 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $4,384,066 | 516,380 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,438,861 | 296,338 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,954,175 | 594,739 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $188,935 | 22,546 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||